Results 211 to 220 of about 157,438 (357)

Machine learning for identifying liver and pancreas cancers through comprehensive serum glycopeptide spectra analysis: a case‐control study

Molecular Oncology, EarlyView.
This study presents a novel AI‐based diagnostic approach—comprehensive serum glycopeptide spectra analysis (CSGSA)—that integrates tumor markers and enriched glycopeptides from serum. Using a neural network model, this method accurately distinguishes liver and pancreatic cancers from healthy individuals.
Motoyuki Kohjima, Yuko Takami, Ken Kawabe, Kazuhiro Tanabe, Chihiro Hayashi, Mikio Mikami, Tetsuya Kusumoto   +6 more
wiley   +1 more source

Inhibition of xanthine oxidase/xanthine dehydrogenase release and cardiovascular permeability by ACE inhibitor (lisinopril) during ischemia-reperfusion in the isolated rat heart

, 1990
Shunichi Shimizu, Yukiko Tsuchida, Shinsuke Kaku, Toshinori Yamamoto, Kazutaka Momose   +4 more
openalex   +1 more source

Case Report: VV-ECMO as a bridge to recovery from ACE inhibitor induced post-obstructive negative pressure pulmonary edema. [PDF]

Front Med (Lausanne)
Smirnova D, Steina E, Klibus M, Prozorovskis E, Strike E, Sabelnikovs O.   +5 more
europepmc   +1 more source

Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-Analysis. [PDF]

Kidney Med, 2022
Campbell KN, Pennese N, Zaffalon A, Magalhaes B, Faiella M, Caster DJ, Radhakrishnan J, Tesar V, Trachtman H.   +8 more
europepmc   +1 more source

Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation

Molecular Oncology, EarlyView.
Cyclin D1 overexpression altered the cell adhesion pathway, while cyclin D2 upregulation had less impact on pathway enrichment analysis. Multiple myeloma (MM) patients with cyclin D1 overexpression showed reduced CD56 expression and increased circulating tumor cells (CTC) levels, suggesting that cyclin D1 may contribute to MM cell dissemination ...
Ignacio J. Cardona‐Benavides, Sara Cristobal‐Vargas, Cristina De Ramón, Elizabeta A. Rojas, Irena Misiewicz‐Krzeminska, Isabel Isidro, José Juan Pérez, Bruno Paiva, Noemi Puig, Miguel Alcoceba, María‐Victoria Mateos, Luis A. Corchete, Myriam Cuadrado, Norma C. Gutiérrez   +13 more
wiley   +1 more source

The Endothelium and Vascular Effects of the ACE Inhibitor Trandolaprilat

, 1994
María Vidal, Ghislaine A. Joly, Jean V. Mombouli, Chantal M. Boulanger, Paul M. Vanhoutte   +4 more
openalex   +1 more source

Does the addition of losartan improve the beneficial effects of ACE inhibitors in patients with anterior myocardial infarction? A pilot study [PDF]

, 1999
P Di Pasquale, Vincenzo Bucca, Sebastiano Scalzo, Sergio Cannizzaro, Alfonso Giubilato, Salvatore Paterna   +5 more
openalex   +1 more source

The role of single-pill ACE inhibitor/ccb combination for hypertension: an Algerian view via the nominal group technique. [PDF]

Future Cardiol
Kichou B, Bouraghda A, Lahmar HMA, Amara S, Aoudia Y, Benchabi Y, Haddoum F, Kachenoura A, Laredj N, Manamani L, Bouafia MTC, Chettibi M.   +11 more
europepmc   +1 more source

ACE inhibitor induced visceral angioedema: an elusive diagnosis. [PDF]

BMJ Case Rep, 2020
Sravanthi MV, Suma Kumaran S, Sharma N, Milekic B.   +3 more
europepmc   +1 more source

β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1

Molecular Oncology, EarlyView.
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero, Alejandro Belmonte‐Fernández, Mónica González‐Moreno, Laura Rodríguez‐Cordero, Begoña Pérez‐Valderrama, Joaquín Herrero‐Ruíz, Francisco Romero, Carmen Sáez, Miguel Á. Japón   +8 more
wiley   +1 more source